Oss-based Citryll secures €85 million Series B funding to advance NET-targeting therapy

Dutch startup Citryll, a biotech innovator in immune-mediated inflammatory diseases, has raised €85 million in a Series B funding round. The financing was co-led ... Read more

Bron:

EU-startups.com